Enzymatic preparation method of black bean albumin ACE inhibitory peptide
Patent Information
- Application Number
- CN202610978110.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-07-02
- Publication Date
- 2026-09-18
AI Technical Summary
为了克服现有酶解黑豆蛋白制备ACE抑制肽方法中的技术难题,如酶解效率低、水解度不高、ACE抑制活性不足的问题,本发明以黑豆清蛋白为原料,筛选Alcalase碱性蛋白酶为最佳水解蛋白酶,通过单因素试验考察各因素对水解度的影响,并采用响应面法优化确定最优酶解工艺参数,可达到较高的水解度和ACE抑制活性
[0024] Beneficial effects: (1) This invention is the first to prepare ACE inhibitory peptides using black soybean albumin as raw material. Compared with black soybean total protein, black soybean albumin has better solubility and is more conducive to the action of proteases. This invention screened Alcalase as the best hydrolytic protease by comparing the hydrolysis effects of six proteases, and optimized the optimal combination of process parameters through single-factor experiments and Box-Benhnken response surface methodology to ensure maximum enzymatic hydrolysis efficiency. (2) Using the optimal enzymatic hydrolysis conditions determined by response surface methodology (pH 11.0, temperature 55℃, enzyme dosage 0.05%, substrate concentration 1%, time 3h), the degree of hydrolysis of black soybean albumin can reach 20.58%, which is significantly higher than that of the prior art. (3) The black soybean albumin hydrolysate prepared by this invention has significant inhibitory activity against ACE. When the concentration of the hydrolysate is 5mg/mL, the ACE inhibition rate reaches 50.34%, and the half-maximal inhibitory concentration (IC50) is 50.34%. 50The concentration was 5.62 mg/mL, indicating that it has good potential for lowering blood pressure. (4) This invention uses black beans as raw material. Black beans are widely planted, abundant in resources, and inexpensive in my country. The protein content is as high as 36%~40%, ranking first among various beans. This can greatly increase the economic added value of black beans and realize the value-added of deep processing of agricultural products. (5) This invention does not require complex purification steps such as ultrafiltration. The process flow is short (extraction → enzymatic hydrolysis → enzyme inactivation → drying four steps), simple to operate, mild enzymatic hydrolysis conditions, and low equipment requirements. It is easy to scale up production and has good industrialization prospects. (6) The ACE inhibitory peptide prepared by this invention is derived from natural black bean protein. It is a food-derived active peptide. Compared with chemically synthesized ACE inhibitory drugs, it has significant advantages such as being non-toxic, having no side effects, and having no adverse effects on people with normal blood pressure. It can be directly applied to health foods or ordinary foods that assist in lowering blood pressure.
Smart Images

Figure CN122772953A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of bioactive peptide preparation technology, specifically relating to a method for preparing angiotensin-converting enzyme (ACE) inhibitory peptides using black soybean albumin as raw material through enzymatic hydrolysis. The black soybean albumin ACE inhibitory peptides prepared by this invention have high safety and few side effects, and can be applied in the fields of blood pressure-lowering functional foods or pharmaceuticals. Background Technology
[0002] Hypertension is a global public health problem and a major risk factor for cardiovascular and cerebrovascular diseases. Angiotensin-converting enzyme (ACE) inhibitory peptides are a collective term for a class of small molecule polypeptides that lower blood pressure by inhibiting ACE activity. They have received widespread attention due to their significant blood pressure-lowering effect and lack of toxic side effects.
[0003] Currently used ACE inhibitors (such as captopril and enalapril) are all chemically synthesized drugs. Although they have significant antihypertensive effects, they have side effects such as cough, angioedema, and rash. In pregnant women, their use may cause irreversible damage or even birth defects to the fetus. Dietary ACE inhibitory peptides, derived from natural food proteins, have advantages such as high safety, few side effects, and no effect on people with normal blood pressure. Grains, seafood, and lactic acid bacteria are all potential food sources for developing ACE inhibitory peptides, and in recent years, dietary ACE inhibitory peptides have become a research hotspot both domestically and internationally.
[0004] Black beans are an important legume resource in my country, with a protein content as high as 36% to 40%, ranking first among various legumes. Black bean protein is rich in complete protein, and its protein is more easily absorbed than that of other legumes, earning it the reputation of "plant-based meat." In addition, black beans contain antioxidants such as vitamin E and anthocyanins, which have effects such as delaying aging and lowering cholesterol. However, current research on the development and utilization of a specific protein component in black beans—albumin—is limited, and research on the process of preparing ACE inhibitory peptides from black bean albumin is still lacking.
[0005] There are existing reports on the preparation of bioactive peptides from black soybean protein using enzymatic hydrolysis (such as Chinese patent application CN107287267A). This method uses black soybean protein powder as raw material, prepares a protein solution with a mass percentage concentration of 10%~40%, performs enzymatic hydrolysis, and then obtains the product through ultrafiltration (retaining 1kDa~3kDa) and freeze drying. However, this technology has the following shortcomings: (1) It uses total black soybean protein as raw material and has not been systematically optimized for specific protein components, so the enzymatic hydrolysis efficiency needs to be improved; (2) The enzymatic hydrolysis process parameters have not been scientifically and systematically optimized, resulting in a low degree of hydrolysis; (3) It requires complex purification steps such as ultrafiltration, which is cumbersome and not conducive to industrial production.
[0006] In summary, there are currently no reports on the preparation of ACE inhibitory peptides using black soybean albumin as raw material and through response surface methodology to systematically optimize the enzymatic hydrolysis process. Summary of the Invention
[0007] The primary objective of this invention is to provide a method for preparing ACE inhibitory peptides from black soybean albumin. To overcome the technical difficulties in existing enzymatic hydrolysis methods for preparing ACE inhibitory peptides from black soybean albumin, such as low hydrolysis efficiency, low degree of hydrolysis, and insufficient ACE inhibitory activity, this invention uses black soybean albumin as raw material, screens Alcalase as the optimal hydrolytic protease, investigates the influence of various factors on the degree of hydrolysis through single-factor experiments, and optimizes and determines the optimal enzymatic hydrolysis process parameters using response surface methodology, achieving a high degree of hydrolysis and ACE inhibitory activity. Furthermore, this invention directly uses black soybean albumin as raw material, eliminating the need for complex purification steps such as ultrafiltration, resulting in a short and simple process flow with promising prospects for industrial application.
[0008] The objective of this invention is achieved through the following technical solution:
[0009] A method for preparing a black soybean albumin ACE inhibitory peptide includes the following steps:
[0010] (1) Extraction of black bean albumin: Black bean isolated protein and deionized water were mixed at a weight ratio of 1:10. After thorough mixing, the mixture was centrifuged and the supernatant was collected. The precipitate was mixed with deionized water again and extracted repeatedly. The supernatants from the two extractions were combined. The pH was adjusted to 4.1, and the precipitate was collected after standing by centrifugation. After washing with water, the pH was adjusted to neutral and the mixture was freeze-dried to obtain black bean albumin.
[0011] (2) Enzymatic hydrolysis: Prepare a solution of black soybean albumin obtained in step (1) with a substrate concentration of 0.5% to 3%, add Alcalase alkaline protease at an enzyme concentration of 0.04% to 0.06%, and hydrolyze for 2.5 to 3.5 hours under the conditions of a hydrolysis pH of 10.5 to 11.5 and a hydrolysis temperature of 50°C to 60°C.
[0012] (3) Enzyme inactivation: After enzymatic hydrolysis, the temperature is raised to inactivate the protease;
[0013] (4) Drying: Freeze-dry the enzymatic hydrolysate to obtain black soybean albumin ACE inhibitory peptide.
[0014] The preferred centrifugation conditions in step (1) are 4000 r / min and 20 min.
[0015] The pH adjustment to 4.1 described in step (1) is preferably performed using 1 mol / L HCl.
[0016] In step (1), adjusting the pH to neutral is preferably done using 1 mol / L NaOH.
[0017] The preferred pH for enzymatic hydrolysis in step (2) is 11.0.
[0018] The preferred enzymatic hydrolysis temperature in step (2) is 55°C.
[0019] The amount of enzyme added in step (2) is preferably 0.05%.
[0020] The substrate concentration in step (2) is preferably 1%.
[0021] The preferred enzymatic hydrolysis time in step (2) is 3 hours.
[0022] The enzyme inactivation described in step (3) is preferably performed by incubating at 90°C for 30 seconds.
[0023] The black soybean albumin ACE inhibitory peptide obtained by the method can be used to prepare health products and food. When used, the black soybean albumin ACE inhibitory peptide can be used alone or in combination with other food and medicine homologous raw materials with antihypertensive effects, and made into health food or ordinary food according to conventional preparation process; the dosage form of the health product is oral liquid, capsule, tablet, powder or granule; the food can be solid beverage or compressed candy.
[0024] Beneficial effects: (1) This invention is the first to prepare ACE inhibitory peptides using black soybean albumin as raw material. Compared with black soybean total protein, black soybean albumin has better solubility and is more conducive to the action of proteases. This invention screened Alcalase as the best hydrolytic protease by comparing the hydrolysis effects of six proteases, and optimized the optimal combination of process parameters through single-factor experiments and Box-Benhnken response surface methodology to ensure maximum enzymatic hydrolysis efficiency. (2) Using the optimal enzymatic hydrolysis conditions determined by response surface methodology (pH 11.0, temperature 55℃, enzyme dosage 0.05%, substrate concentration 1%, time 3h), the degree of hydrolysis of black soybean albumin can reach 20.58%, which is significantly higher than that of the prior art. (3) The black soybean albumin hydrolysate prepared by this invention has significant inhibitory activity against ACE. When the concentration of the hydrolysate is 5mg / mL, the ACE inhibition rate reaches 50.34%, and the half-maximal inhibitory concentration (IC50) is 50.34%. 50The concentration was 5.62 mg / mL, indicating that it has good potential for lowering blood pressure. (4) This invention uses black beans as raw material. Black beans are widely planted, abundant in resources, and inexpensive in my country. The protein content is as high as 36%~40%, ranking first among various beans. This can greatly increase the economic added value of black beans and realize the value-added of deep processing of agricultural products. (5) This invention does not require complex purification steps such as ultrafiltration. The process flow is short (extraction → enzymatic hydrolysis → enzyme inactivation → drying four steps), simple to operate, mild enzymatic hydrolysis conditions, and low equipment requirements. It is easy to scale up production and has good industrialization prospects. (6) The ACE inhibitory peptide prepared by this invention is derived from natural black bean protein. It is a food-derived active peptide. Compared with chemically synthesized ACE inhibitory drugs, it has significant advantages such as being non-toxic, having no side effects, and having no adverse effects on people with normal blood pressure. It can be directly applied to health foods or ordinary foods that assist in lowering blood pressure. Attached Figure Description
[0025] To clearly illustrate the embodiments and related technical solutions of the present invention, the accompanying drawings involved in the embodiments will be briefly described below. It should be understood that the following drawings are only for illustrating some embodiments of the present invention. Those skilled in the art can also obtain other related technical solutions and drawings based on these drawings without any inventive effort.
[0026] Figure 1 This study investigated the effect of different proteases on the degree of hydrolysis of black soybean albumin.
[0027] Figure 2 This describes the effect of pH on the degree of hydrolysis of black soybean albumin.
[0028] Figure 3 This study investigates the effect of enzymatic hydrolysis temperature on the degree of hydrolysis of black soybean albumin.
[0029] Figure 4 This study investigated the effect of enzyme dosage on the degree of hydrolysis of black soybean albumin.
[0030] Figure 5 This study investigated the effect of enzymatic hydrolysis time on the degree of hydrolysis of black soybean albumin.
[0031] Figure 6 This study investigated the effect of substrate concentration on the degree of hydrolysis of black soybean albumin.
[0032] Figure 7 These are response surface plots and contour plots showing the effects of pH and enzymatic hydrolysis temperature on the degree of hydrolysis.
[0033] Figure 8 These are response surface plots and contour plots showing the effects of pH and enzyme dosage on the degree of hydrolysis.
[0034] Figure 9 These are response surface plots and contour plots showing the effect of enzymatic hydrolysis temperature and enzyme dosage on the degree of hydrolysis.
[0035] Figure 10 The inhibition rate of ACE by different concentrations of black soybean albumin hydrolysate is shown. Detailed Implementation
[0036] To clearly illustrate the embodiments of the present invention, a detailed description will be provided below in conjunction with the accompanying drawings. It should be understood that the following description in conjunction with the accompanying drawings is merely exemplary and intended to explain the present invention, and should not be construed as limiting the present invention.
[0037] In the following embodiments, the measurement methods are as follows:
[0038] The main components of black soybeans were determined as follows: moisture content was determined according to the standard GB5009.3-2016; crude fat content was determined according to the standard GB5009.6-2016; crude protein content was determined according to the standard GB5009.5-2016; and ash content was determined according to the standard GB5009.4-2016.
[0039] Degree of hydrolysis determination: The degree of hydrolysis of black soybean albumin was determined by pH-stat method. Sodium hydroxide was added dropwise during the enzymatic hydrolysis process to maintain the pH value of the hydrolysate, the amount of sodium hydroxide consumed was recorded, and the degree of hydrolysis was calculated.
[0040] ACE inhibition rate determination: The Cushman method was referenced and modified. Hippuric acid-histidine-leucine (HHL) was used as a substrate and reacted with ACE enzyme and the test sample at 37°C. After the reaction was completed, hydrochloric acid was added to terminate the reaction. After hippuric acid was extracted with ethyl acetate, the absorbance was measured at 228 nm, and the ACE inhibition rate was calculated.
[0041] Example 1
[0042] A method for preparing a black soybean albumin ACE inhibitory peptide includes the following steps:
[0043] (1) Extraction of black soybean albumin: Black soybean protein isolate was mixed with deionized water at a weight ratio of 1:10 and thoroughly mixed for 1 hour. After centrifugation at 4000 r / min for 20 minutes, the supernatant was collected. The precipitate was mixed with deionized water again for repeated extraction, and the supernatants from both extractions were combined. The pH was adjusted to 4.1 by adding 1 mol / L HCl and allowed to stand for 1 hour. The precipitate was collected by centrifugation at 4000 r / min for 20 minutes, washed three times with water, and the pH was adjusted to 7.0 by adding 1 mol / L NaOH. The precipitate was then freeze-dried under vacuum to obtain black soybean albumin.
[0044] (2) Enzymatic hydrolysis: The black bean albumin obtained in step (1) was prepared into a substrate concentration of 1%, and Alcalase alkaline protease was added at a concentration of 0.05%. Enzymatic hydrolysis was carried out for 3 hours at a pH of 11.0 and a temperature of 55°C.
[0045] (3) Inactivation of enzymes: After the enzymatic hydrolysis is completed, the temperature is raised to 90℃ and kept for 30 seconds to inactivate the protease.
[0046] (4) Drying: Freeze-dry the enzymatic hydrolysate to obtain black soybean albumin ACE inhibitory peptide.
[0047] The degree of hydrolysis of the black soybean albumin ACE inhibitory peptide obtained in this example was determined to be 20.58%. A 5 mg / mL solution of the hydrolysate was prepared and, according to the ACE inhibition rate determination method described above, the ACE inhibition rate was 50.34%, with an IC50 value of [missing information]. 50 It is 5.62 mg / mL.
[0048] Example 2
[0049] The enzymatic hydrolysis pH was 10.5, and the other conditions were the same as in Example 1. The degree of hydrolysis of the black soybean albumin ACE inhibitory peptide obtained in this example was determined to be 19.37%.
[0050] Example 3
[0051] The enzymatic hydrolysis pH was 11.5, and the other conditions were the same as in Example 1. The degree of hydrolysis of the black soybean albumin ACE inhibitory peptide obtained in this example was determined to be 18.02%.
[0052] Example 4
[0053] The enzymatic hydrolysis temperature was 50℃, and other conditions were the same as in Example 1. The degree of hydrolysis of the black soybean albumin ACE inhibitory peptide obtained in this example was determined to be 18.25%.
[0054] Example 5
[0055] The enzymatic hydrolysis temperature was 60℃, and other conditions were the same as in Example 1. The degree of hydrolysis of the black soybean albumin ACE inhibitory peptide obtained in this example was determined to be 18.99%.
[0056] Example 6
[0057] The enzyme dosage was 0.04%, and the other conditions were the same as in Example 1. The degree of hydrolysis of the black soybean albumin ACE inhibitory peptide obtained in this example was determined to be 17.80%.
[0058] Example 7
[0059] The enzyme dosage was 0.06%, and the other conditions were the same as in Example 1. The degree of hydrolysis of the black soybean albumin ACE inhibitory peptide obtained in this example was determined to be 18.12%.
[0060] Comparative Example 1
[0061] The same conditions as in Example 1 were used, but papain was used instead of alcalase. The degree of hydrolysis of the black soybean enzymatic hydrolysate obtained in this comparative example was determined to be significantly lower than that in Example 1.
[0062] Comparative Example 2
[0063] The same conditions as in Example 1 were used, but black soybean total protein (instead of albumin) was used as the raw material. The degree of hydrolysis of the enzymatic hydrolysate obtained in this comparative example was determined to be significantly lower than that in Example 1.
[0064] Comparative Example 3
[0065] The same conditions as in Example 1 were used, but the enzymatic hydrolysis pH was 10.0, the enzymatic hydrolysis temperature was 45°C, and the enzyme dosage was 0.02%. The degree of hydrolysis of the black soybean enzymatic hydrolysate obtained in this comparative example was significantly lower than that in Example 1.
[0066] Table 1. Degree of hydrolysis of black soybean albumin ACE inhibitory peptides obtained in each example.
[0067]
[0068] As shown in Table 1, the black soybean albumin ACE inhibitory peptide prepared by the method of the present invention (Example 1) can reach a degree of hydrolysis of 20.58% under optimal conditions. Although Examples 2-7 also adopted the basic steps of the method of the present invention, the degree of hydrolysis was lower than that of Example 1 because the enzymatic hydrolysis pH, temperature or enzyme dosage deviated from the optimal values. This indicates that the combination of process parameters determined by response surface methodology in the present invention has the best hydrolysis effect.
[0069] Furthermore, the black soybean albumin ACE-inhibiting peptide obtained in Example 1 was prepared into solutions of different concentrations, and its inhibitory activity against ACE was measured. As the concentration gradually increased from 1 mg / mL to 7 mg / mL, the ACE inhibition rate gradually increased; when the concentration was 5 mg / mL, the ACE inhibition rate reached its maximum value of 50.34%, and when the concentration was further increased to 7 mg / mL, the ACE inhibition rate tended to stabilize. This indicates that the black soybean albumin ACE-inhibiting peptide prepared in this invention has good ACE inhibitory activity and can be used as an effective ingredient in auxiliary antihypertensive foods or health products.
[0070] In summary, although the present invention has been described in detail above with reference to specific embodiments, the scope of protection of the present invention is not limited to the specific embodiments described. Those skilled in the art can modify, alter, or adapt these embodiments without departing from the principles of the present invention. All such changes or substitutions based on the inventive concept should be covered within the scope of protection of the present invention.
Claims
1. A method for preparing a black soybean albumin ACE inhibitory peptide, characterized in that, Includes the following steps: (1) Extraction of black soybean albumin: Mix black soybean albumin with deionized water at a weight ratio of 1:10, centrifuge after thorough mixing, and collect the supernatant; mix the precipitate with deionized water again and repeat the extraction, and combine the two supernatants; adjust the pH to 4.1, centrifuge after standing to collect the precipitate, wash with water and adjust the pH to neutral, freeze dry to obtain black soybean albumin; (2) Enzymatic hydrolysis: prepare the black soybean albumin obtained in step (1) into a solution with a substrate concentration of 0.5%~3%, add Alcalase alkaline protease, the amount of enzyme added is 0.04%~0.06%, and enzymatic hydrolysis is carried out for 2.5h~3.5h under the conditions of pH 10.5~11.5 and temperature 50℃~60℃; (3) Enzyme inactivation: after enzymatic hydrolysis, heat up to inactivate the protease; (4) Drying: freeze dry the enzymatic hydrolysate to obtain black soybean albumin ACE inhibitory peptide.
2. The preparation method according to claim 1, characterized in that: The enzymatic hydrolysis in step (2) is performed at pH 11.
0.
3. The preparation method according to claim 1, characterized in that: The enzymatic hydrolysis temperature in step (2) is 55℃.
4. The preparation method according to claim 1, characterized in that: The amount of enzyme added in step (2) is 0.05%.
5. The preparation method according to claim 1, characterized in that: The substrate concentration in step (2) is 1%.
6. The preparation method according to claim 1, characterized in that: The enzymatic hydrolysis time in step (2) is 3 hours.
7. A black soybean albumin ACE inhibitory peptide, characterized in that: It is prepared by the method described in any one of claims 1-6.
Citation Information
Patent Citations
Preparation of black-bean ACE (Angiotensin Converting Enzyme) inhibitory peptide by enzymolysis method
CN107287267A
